Maze Therapeutics, Inc.
MAZENASDAQHealthcare● Active
$23.58
$-0.69(-2.84%)
Market Cap$1.3B
P/E Ratio—
52W High$53.65
52W Low$9.83
Maze Therapeutics, Inc.（MAZE）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · MAZE · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $0.00B | $0.17B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.00B) | $0.17B | $0.00B | $0.00B |
| Gross Margin %(computed) | — | 100.00% | — | — |
| Operating Expenses | ||||
| R&D Expenses | $0.11B | $0.08B | $0.07B | $0.09B |
| G&A Expenses | $0.03B | $0.03B | $0.02B | $0.02B |
| Total Operating Expenses | $0.14B | $0.11B | $0.10B | $0.11B |
| Operating Income | ($0.14B) | $0.06B | ($0.10B) | ($0.11B) |
| Operating Margin %(computed) | — | 34.38% | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.13B) | $0.05B | ($0.10B) | ($0.11B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.13B) | $0.05B | ($0.10B) | ($0.11B) |
| Net Margin %(computed) | — | 31.18% | — | — |
| Per Share & EBITDA | ||||
| EPS (Basic) | $-3.05 | $0.08 | $-2.29 | $-2.63 |
| Wtd Avg Shares | 0.04B | 0.04B | 0.04B | 0.04B |
| EBITDA | ($0.14B) | $0.06B | ($0.09B) | ($0.11B) |
| EBITDA Margin %(computed) | — | 36.35% | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · B
深入了解Maze Therapeutics, Inc.
关于Maze Therapeutics, Inc.（MAZE）损益表
Maze Therapeutics, Inc.（MAZE）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，MAZE实现营收$0.00B，毛利润($0.00B)（毛利率—），净利润($0.13B)（净利率—）。
常见问题
MAZE · 4 问Maze Therapeutics, Inc.（MAZE）2025财年营收为$0.00B，同比down100.0%。
MAZE revenueMAZE salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09